ICICI Securities Limited
In the US, Sun diversifying into specialty products like Ilumya, Levulan, BromSite, Cequa, Xelpros, Odomzo, Yonsa, winlwvi etc. Key Risk: (i) Price erosion impact...
Motilal Oswal released a Buy report for Sun Pharmaceutical Industries Ltd. with a price target of 1960.0 on 23 Sep, 2025.
More from Sun Pharmaceutical Industries Ltd.
Recommended